Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ErbB-2 inhibitor ARRY-380
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
ARRY-380 and Trastuzumab in Treating Brain Metastases in Patients with HER2-Positive Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-198, NCI-2013-01827, ARRAY-380-104X, NCT01921335
A Phase 1b Study of ONT-380 Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: ONT-380-004, NCI-2014-00007, NCT01983501
A Phase 1b Study of ONT-380 Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ONT-380-005, NCI-2014-00546, NCT02025192
Start Over